Yi Ping Rong
Net worth: 48 259 $ as of 2026-06-29
Net worth: 48 259 $ as of 2026-06-29
Yi Ping Rong is Executive Director & Senior Vice President at Harbour BioMed (Shanghai) Co., Ltd. since 2016.
Dr. Rong is Executive Director, Chief Scientific Officer & SVP at HBM Holdings Ltd. since 2022.
Former roles include Member at The American Association of Cancer Research.
Education includes a doctorate from Case Western Reserve University conferred in 2008 and a graduate degree from East China University of Science & Technology conferred in 2002.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-09-04 | 36,250 ( 0% ) | 48 259 $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| HBM HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 2022-05-04 |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Director/Board Member | - |
| Companies | Position | End |
|---|---|---|
The American Association of Cancer Research | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
East China University of Science & Technology
East China University of Science & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Engages in discovering and developing innovative therapeutics for cancer | Health Technology |
HBM Holdings Ltd.
HBM Holdings Ltd. Pharmaceuticals: OtherHealth Technology Engages in research and development of therapeutics in the fields of immuno-oncology and immunology diseases | Health Technology |
The American Association of Cancer Research |
Select your edition
All financial news and data tailored to specific country editions